Drugs / CAR 70-BCMA CAR-T
last change Apr 2026 re-read 3 minutes ago

CAR 70-BCMA CAR-T

Developed for
plasma cell neoplasm
Investigated by
The General Hospital of Western Theater Command

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07519187 Apr 2026 → Apr 2027 expected plasma cell neoplasm The General Hospital of Western Theater Command Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CAR 70-BCMA CAR-T ClinicalTrials.gov intervention name — accepted as the source's own label NCT07519187 ↗
Route Intravenous “Route of administration: Intravenous injection.” NCT07519187 ↗